Petroková Hana, Dusková Jarmila, Dohnálek Jan, Skálová Tereza, Vondrácková-Buchtelová Eva, Soucek Milan, Konvalinka Jan, Brynda Jirí, Fábry Milan, Sedlácek Juraj, Hasek Jindrich
Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Praha, Czech Republic.
Eur J Biochem. 2004 Nov;271(22):4451-61. doi: 10.1111/j.1432-1033.2004.04384.x.
The crystal structure of the complex between human immunodeficiency virus type 1 (HIV-1) protease and a peptidomimetic inhibitor of ethyleneamine type has been refined to R factor of 0.178 with diffraction limit 2.5 A. The peptidomimetic inhibitor Boc-Phe-Psi[CH2CH2NH]-Phe-Glu-Phe-NH2 (denoted here as OE) contains the ethyleneamine replacement of the scissile peptide bond. The inhibitor lacks the hydroxyl group which is believed to mimic tetrahedral transition state of proteolytic reaction and thus is suspected to be necessary for good properties of peptidomimetic HIV-1 protease inhibitors. Despite the missing hydroxyl group the inhibition constant of OE is 1.53 nm and it remains in the nanomolar range also towards several available mutants of HIV-1 protease. The inhibitor was found in the active site of protease in an extended conformation with a unique hydrogen bond pattern different from hydroxyethylene and hydroxyethylamine inhibitors. The isostere nitrogen forms a hydrogen bond to one catalytic aspartate only. The other aspartate forms two weak hydrogen bridges to the ethylene group of the isostere. A comparison with other inhibitors of this series containing isostere hydroxyl group in R or S configuration shows different ways of accommodation of inhibitor in the active site. Special attention is devoted to intermolecular contacts between neighbouring dimers responsible for mutual protein adhesion and for a special conformation of Met46 and Phe53 side chains not expected for free protein in water solution.
1型人类免疫缺陷病毒(HIV-1)蛋白酶与一种乙二胺型拟肽抑制剂复合物的晶体结构已被精修至R因子为0.178,衍射极限为2.5埃。该拟肽抑制剂Boc-Phe-Psi[CH2CH2NH]-Phe-Glu-Phe-NH2(此处记为OE)含有对可裂解肽键的乙二胺替代。该抑制剂缺乏被认为模拟蛋白水解反应四面体过渡态的羟基,因此被怀疑是拟肽HIV-1蛋白酶抑制剂良好性能所必需的。尽管缺少羟基,但OE的抑制常数为1.53纳摩尔,对几种现有的HIV-1蛋白酶突变体其抑制常数也保持在纳摩尔范围内。发现该抑制剂在蛋白酶活性位点呈伸展构象,具有与羟基乙烯和羟乙胺抑制剂不同的独特氢键模式。等排体氮仅与一个催化天冬氨酸形成氢键。另一个天冬氨酸与等排体的乙烯基团形成两个弱氢键桥。与该系列在R或S构型中含有等排体羟基的其他抑制剂相比,显示出抑制剂在活性位点的不同容纳方式。特别关注相邻二聚体之间的分子间接触,这些接触负责蛋白质间的相互黏附以及Met46和Phe53侧链的特殊构象,而在水溶液中的游离蛋白质中这种构象是未预期到的。